Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Publication year range
1.
Metab Brain Dis ; 36(7): 1481-1499, 2021 10.
Article in English | MEDLINE | ID: mdl-34264451

ABSTRACT

Bipolar disorder (BD) is a complex psychiatric disease characterized by mood swings that include episodes of mania and depression. Given its cyclical nature, BD is especially hard to model; however, the standard practice has been to mimic manic episodes in animal models. Despite scientific advances, the pathophysiology of BD is not fully understood, and treatment remains limited. In the last years, natural products have emerged as potential neuroprotective agents for the treatment of psychiatric diseases. Thus, the aim of this review was to explore the therapeutic potential of natural compounds and derivatives against BD, taking into account preclinical and clinical studies. Reliable articles indexed in databases such as PubMed, Web of Science and Science Direct were used. In clinical studies, treatment with herbal plants extracts, omega-3, inositol, n-acetylcysteine and vitamin D has been associated with a clinical improvement in symptoms of mania and depression in BD patients. In animal models, it has been shown that red fruits extracts, curcumin, quercetin, gallic acid, alpha-lipoic acid and carvone can modulate many neurochemical pathways involved in the pathophysiology of manic episodes. Thus, this review appointed the advances in the consumption of natural compounds and derivatives as an important therapeutic strategy to mitigate the symptoms of BD.


Subject(s)
Biological Products/therapeutic use , Bipolar Disorder/drug therapy , Mania/drug therapy , Animals , Disease Models, Animal , Fatty Acids, Omega-3/therapeutic use , Gallic Acid/therapeutic use , Humans , Inositol/therapeutic use , Plant Extracts/therapeutic use , Quercetin/therapeutic use
2.
Int J Dev Neurosci ; 81(2): 167-178, 2021 Apr.
Article in English | MEDLINE | ID: mdl-33394512

ABSTRACT

Bipolar disorder is characterized by episodes of depression and mania, and oxidative stress has been associated with the observed neurochemical changes in this disease. We evaluated the effects of gallic acid on hyperlocomotion, acetylcholinesterase activity, and oxidative stress in an animal model of ketamine-induced mania. Rats were pretreated orally with vehicle, gallic acid (50 or 100 mg/kg), or lithium (45 mg/kg twice a day) for 14 days. Between days 8 and 14, the animals also received ketamine (25 mg/kg) or saline daily. On the 15th day, hyperlocomotion was assessed, following which the animals were euthanized, and brains were collected. Results showed that ketamine-induced hyperlocomotion and caused oxidative damage by increasing reactive oxygen species levels, lipid peroxidation, and nitrite levels, and decreasing the total thiol content and the activities of catalase, superoxide dismutase, and glutathione peroxidase in the brain. Pretreatment with gallic acid and lithium prevented hyperlocomotion and brain oxidative damage. Further, ketamine increased the acetylcholinesterase activity in the hippocampus and striatum, whereas gallic acid and lithium ameliorated this alteration. Thus, gallic acid may provide effective protection against manic-like behavior by reducing oxidative stress and preventing cholinergic signaling dysfunction in the brain regions involved in emotion regulation.


Subject(s)
Cerebral Cortex/drug effects , Corpus Striatum/drug effects , Gallic Acid/therapeutic use , Hippocampus/drug effects , Lithium/therapeutic use , Mania/drug therapy , Animals , Cerebral Cortex/metabolism , Corpus Striatum/metabolism , Disease Models, Animal , Gallic Acid/pharmacology , Hippocampus/metabolism , Lithium/pharmacology , Male , Mania/metabolism , Motor Activity/drug effects , Oxidative Stress/drug effects , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism
3.
Rev. Inst. Adolfo Lutz ; 68(2): 192-200, maio-ago. 2009. tab, graf
Article in Portuguese | LILACS, Sec. Est. Saúde SP, SESSP-CTDPROD, Sec. Est. Saúde SP, SESSP-ACVSES, SESSP-IALPROD, Sec. Est. Saúde SP, SESSP-IALACERVO | ID: lil-544603

ABSTRACT

O objetivo deste trabalho foi estabelecer as melhores condições para efetuar extração de compostos fenólicos totais de diferentes classes comerciais de cebola (Allium cepa L.). Por meio de Planejamento Experimental Fatorial foram determinadas as variáveis que influenciam significativamente nas etapas de extração. As variáveis estudadas foram: natureza do solvente, procedimento de agitação, tempo de extração e tempo de agitação com e sem interrupções. A melhor combinação resultou em um modelo preditivo, empregando semetanol como solvente, agitação de 120 minutos a 200 rpm. O maior conteúdo fenólico em diferentes classes de cebola foi 2275 μg/g, 88% de recuperação e o limite de quantificação foi de 31 μg fenóis/g.


Subject(s)
Onions , Phenolic Compounds , Spices
SELECTION OF CITATIONS
SEARCH DETAIL
...